Diplomat Specialty Pharmacy® and Diplomat Specialty Infusion Group® are joining the Optum® family.

To learn more about what this means for you, visit our FAQ pages:

Specialty Pharmacy FAQ  •  Infusion Pharmacy FAQ

Learn More About Chronic Inflammatory Demyelinating Polyneuropathy


Learn More About Chronic Inflammatory Demyelinating Polyneuropathy

One of the first steps after a chronic inflammatory demyelinating polyneuropathy (CIDP) diagnosis is understanding the condition. Diplomat is here to help. 


Chronic inflammatory demyelinating polyneuropathy occurs as a result of damage to the myelin sheath, the fatty covering that protects nerve fibers within the body. CIDP, also known as chronic relapsing polyneuropathy, results in muscles weakness and reduced sensitivity in extremities. Patients might experience tingling, numbness, fatigue and loss of deep tendon reflexes.

CIDP can occur at any time, but it is typically diagnosed in young adults. Males are more prone to experience CIDP than females.

The course of the disease varies, with some patients seeing spontaneous recovery while others suffer chronically. With the early treatment, people living with the disorder can go into remission and live without side effects for extended periods.


National Institute of Neurological Disorders and Stroke

The information contained herein may not be construed as medical advice. It is for educational purposes only. Diplomat Pharmacy Inc. takes no responsibility for the accuracy or validity of the information contained herein, nor the claims or statements of any manufacturer.